Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke.

Autor: Alexandrov AV; Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Suite 415, Memphis, TN 38163, USA., Tsivgoulis G; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA., Köhrmann M; Department of Neurology, Universitaetsklinikum Erlangen, Erlangen, Germany., Katsanos AH; Second Department of Neurology, 'Attikon' University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Soinne L; Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, Neurology, University of Helsinki Helsinki, Finland., Barreto AD; Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, USA., Rothlisberger T; Cerevast Therapeutics, Inc., Redmond, WA, USA., Sharma VK; Yong Loo Lin School of Medicine, National University of Singapore and Division of Neurology, Department of Medicine, National University Hospital, Singapore, Singapore., Mikulik R; International Clinical Research Centre and Department of Neurology, St. Anne's University Hospital in Brno and Medical Faculty, Masaryk University, Brno, Czech Republic., Muir KW; Institute of Neuroscience and Psychology, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Levi CR; Department of Neurology, John Hunter Hospital, University of Newcastle, Newcastle, Australia., Molina CA; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain., Saqqur M; Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, Canada., Mavridis D; Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece., Psaltopoulou T; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Vosko MR; Department of Neurology 2, Med Campus III, Kepler University Hospital, Linz, Austria., Fiebach JB; Center for Stroke Research Berlin, Charité-University Medicine Berlin, Berlin, Germany., Mandava P; Stroke Outcomes Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX, USA., Kent TA; Stroke Outcomes Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX, USA., Alexandrov AW; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA., Schellinger PD; Departments of Neurology and Neurogeriatry, John Wesling Medical Center Minden, Ruhr University Bochum, Minden, Germany.

Publikováno v: Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2019 Jul 12; Vol. 12, pp. 1756286419860652. Date of Electronic Publication: 2019 Jul 12 (Print Publication: 2019).